Chiral Drugs via Biocatalytical Approaches

Chiral Drugs: Chemistry and Biological Action

Volumn , Issue , 2011, Pages 77-136

  Wang, Jianqiang ^a   Lu, Wenya ^b  

^a ARQULE INC   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Biocatalysis in pharmaceutical industry chiral drugs via biocatalytical approaches, breakthroughs in genomics and proteomics; Biosynthesis, natural products rich source of biologically active compounds, applications in human therapeutics; Chiral drugs via biocatalytical approaches

Indexed keywords

EID: 84879223815     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118075647.ch3     Document Type: Chapter

References (175)

1. Bommarius, A. S., Riebel, B. R. (2004). Biocatalysis: Fundamentals and Applications. Wiley-VCH.
2. Aehle, W. Ed. (2007). Enzymes in Industry: Production and Applications. 3 rd ed., Wiley-VCH.
3. Tao, J. H., Lin, G. Q., Liese, A. (eds). (2008). Biocatalysis for the Pharmaceutical Industry: Discovery, Development, and Manufacturing. John Wiley & Sons, Inc.
4. Patel, R. N. (ed). (2006). Biocatalysis in the Pharmaceutical and Biotechnology Industries. CRC.
5. Liese, A., Seelbach, K., Wandrey, C. (eds). (2006). Industrial Biotransformations. Wiley-VCH.
6. Hou, C. T. (eds). (2005). Handbook of Industrial Biocatalysis. CRC.
7. Illanes, A. (ed). (2008). Enzyme Biocatalysis: Principles and Applications. Springer.
8. Stephanopoulos, G. (1999). Metabolic fluxes and metabolic engineering. Metab. Eng. 1, 1-11.
9. Buckland, B. C., Robinson, D. K., Chartrain, M. (2000). Biocatalysis for pharmaceuticals-status and prospects for a key technology. Metab. Eng. 2, 42-48.
10. Xu, Z., Singh, J., Schwinden, M. D., Zheng, B., Kissick, T. P., Patel, B., Humora, M. J., Quiroz, F., Dong, L., Hsieh, D. M., Heikes, J. E., Pudipeddi, M., Lindrud, M. D., Srivastava, S. K., Kronenthal, D. R., Mueller, R. H. (2002). Process research and development for an efficient synthesis of the HIV protease inhibitor BMS-232632. Org. Proc. Res. Dev. 6, 323-328.
11. Patel, R. N., Chu, L., Muller, R. (2003). Diastereoselective microbial reduction of (S)-[3-chloro-2-1-(phenylmethyl)propyl]carbamic acid, 1, 1-dimethylethyl ester. Tetrahedron Asymmetry 14, 3105-9109.
12. Bommarius, A. S., Schwarm, M., Stingl, M., Kotterhahn, K., Huthmacher, K., Drauz, K. Synthesis and use of enantiomerically pure tert-leucine. (1995). Tetrahedron Asymmetry 6, 2851-2888.
13. Wichmann, R., Wandrey, C., Bückmann, A. F., Kula, M. R. (1981). Continuous enzymatic transformation in an enzyme membrane reactor with simultaneous NAD(H) regeneration. Reprinted from Biotechnol. Bioeng. vol. XXIII, no. 12, p. 2789-2802.
14. Wichmann, R. Wandrey, C. (2000). Continuous enzymatic transformation in an enzyme membrane reactor with simultaneous NAD(H) regeneration. Biotechnol. Bioeng. 67, 791-804.
15. Jacobsen, E. N., Zhang, W., Muci, A. R., Ecker, J. R., Deng, L. (1991). Highly enantioselective epoxidation catalysts derived from 1, 2-diaminocyclohexane. J. Am. Chem. Soc. 113, 7063-7064.
16. Larrow, J. F., Jacobsen, E. N. (1994). Kinetic resolution of 1, 2-dihydronaphthalene oxide and related epoxides via asymmetric C-H hydroxylation. J. Am. Chem. Soc. 116, 12129-12130.
17. Senanayake, C. H., Roberts, F. E., DiMichele, L. M., Ryan, K. M., Liu, J., Fredenburgh, L. E., Foster, B. S., Douglas, A. W., Larsen, R. D., Verhoeven, T. R., Reider, P. J. (1995). The behavior of indene oxide in the Ritter reaction: a simple route to cisaminoindanol. Tetrahedron Lett. 36, 3993-3996.
18. Senanayake, C. H., Smith, G. B., Ryan, K. M., Fredenburgh, L. E., Liu, J., Roberts, F. E., Hughes, D. L., Larsen, R. D., Verhoeven, T. R., Reider, P. J. (1996). The role of 4-(3-phenylpropyl)pyridine Noxide (P3NO) in the manganese-salen-catalyzed asymmetric epoxidation of indene. Tetrahedron Lett. 37, 3271-3274.
19. Senanayake, C. H., DiMichele, L. M., Liu, J., Fredenburgh, L. E., Ryan, K. M., Roberts, F. E., Larsen, R. D., Verhoeven, T. R., Reider, P. J. (1995). Regio-and stereocontrolled syntheses of cyclic chiral cis-amino alcohols from 1, 2-diols or epoxides. Tetrahedron Lett. 36, 7615-7618.
20. Zhang, J., Reddy, J., Roberge, C., Senanayake, C., Greasham, R., Chartrain, M. (1995). Chiral bio-resolution of racemic indene oxide by fungal epoxide hydrolases. J. Ferment. Bioeng. 80, 244-246.
21. Buckland, B. C., Drew, S. W., Connors, N. C., Chartrain, M. M., Lee, C., Salmon, P. M., Gbewonyo, K., Zhou, W., Gailliot, P., Singhvi, R., Olewinski, R. C., Sun, W. J., Reddy, J., Zhang, J., Jackey, B. A., Taylor, C., Goklen, K. E., Junker, B., Greasham, R. L. (1999). Microbial conversion of indene to indandiol: a key intermediate in the synthesis of Crixivan. Meta. Eng. 1, 63-74.
22. Zhang, N., Stewart, B. G., Moore, J. C., Greasham, R. L., Robinson, D. K., Buckland, B. C., Lee, C. (2000). Directed evolution of toluene dioxygenase from Pseudomonas putida for improved selectivity toward cis-indandiol during indene bioconversion. Metab. Eng. 2, 339-348.
23. Buckland, B. C., Robinson, D. K., Chartrain, M. (2000). Biocatalysis for pharmaceuticals-status and prospects for a key technology. Metab. Eng. 2, 42-48.
24. Shirae, H., Yokozeki, K. (1991). Purifications and properties of orotidinephosphorolyzing enzyme and purine nucleoside phosphorylase from Erwinia carotovora AJ 2992. Agric. Biol. Chem. 55, 1849-1857.
25. Shirae, H., Yokozeki, K., Kubota, K. (1988). Enzymatic production of ribavirin from pyrimidine nucleosides by Enterobacter aerogenes AJ 11125. Agric. Biol. Chem. 52, 1233-1237.
26. Shirae, H., Yokozeki, K., Kubota, K. (1988). Enzymatic production of ribavirin from orotidine by Erwinia carotovora AJ 2992. Agric. Biol. Chem. 52, 1499-1504.
27. Shirae, H., Yokozeki, K., Kubota, K. (1988). Enzymatic production of ribavirin from purine nucleosides by Brevibacterium acetylicum AJ 1442. Agric. Biol. Chem. 52, 1777-1783.
28. Shirae, H., Yokozeki, K., Kubota, K. (1988). Enzymatic production of ribavirin. Agric. Biol. Chem. 52, 295-296.
29. Tamarez, M., Morgan, B., Wong, G. S. K., Tong, W., Bennett, F., Lovey, R., McCormick, J. L., Zaks, A. (2003). Pilot-scale lipase-catalyzed regioselective acylation of ribavirin in anhydrous media in the synthesis of a novel prodrug intermediate. Org. Process Res. Dev. 7, 951-953.
30. Patel, R. N. (2006). Biocatalysis in the Pharmaceutical and Biotechnology Industries. CRC Press, p. 648-651.
31. Hoekstra, M. S., Sobieray, D. M., Schwindt, M. A., Mulhern, T. A., Grote, T. M., Huckabee, B. K., Hendrickson, V. S., Franklin, L. C., Granger, E. J., Karrick, G. L. (1997). Chemical development of CI-1008, an enantiomerically pure anticonvulsant. Org. Proc. Res. Dev. 1, 26-38.
32. Burk, M., de Koning, P. D., Grote, T. M., Hoekstra, M. S., Hoge, G., Jennings, R. A., Kissel, W. S., Le, T. V., Lennon, I. C., Mulhern, T. A., Ramsden, J. A., Wade, R. A. (2003). An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation. J. Org. Chem. 68, 5731-5734.
33. Hu, S., Martinez, C. A., Tao, J., Tully, W. E., Kelleher, P., Yves, D. (2005). Preparation of pregabalin and related compounds. US20050283023.
34. Xie, Z., Feng, J., Garcia, E., Bernett, M., Yazbeck, D., Tao, J. (2006). Cloning and optimization of a nitrilase for the synthesis of (3S)-3-cyano-5-methyl hexanoic acid. J. Mol. Catal. B Enzym. 41, 75-80.
35. Burns, M. P., Weaver, J. K., Wong, J. W. (2005). Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids. WO20050100580.
36. Jacobsen, E. N., Deng, L., Furukawa, Y., Martinez, L. (1994). Enantioselective catalytic epoxidation of cinnamate esters. Tetrahedron 50, 4323-4334.
37. Hulshof, L. A., Roskan, J. H. (1994). Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem. EP0343714/1994.
38. Shibatani, T., Nakamichi, K., Matsumae, H. (1990). Method for preparing optically active 3-phenylglycidic acid esters. EP0362556/1990.
39. Seki, M., Furutani, T., Imashiro, R., Kuroda, T., Yamanaka, T., Harada, N., Arakawa, H., Kusama, M., Hashiyama, T. (2001). A novel synthesis of a key intermediate for diltiazem. Tetrahedron Lett. 42, 8201-8205.
40. Schwatz, A., Madan, P. B., Mohacsi, E., O'Brien, J. P., Todaro, L. J., Coffen, D. L. (1992). Enantioselective synthesis of calcium channel blockers of the diltiazem group. J. Org. Chem. 57, 851-856.
41. Evans, C. T., Roberts, S. M., Shoberu, K. A., Sutherland, A. G. (1992). Potential use of carbocyclic nucleosides for the treatment of AIDS: chemo-enzymatic synthesis of the enantiomers of carbovir. J. Chem. Soc. Perkin Trans. 1, 589-592.
42. Taylor, S. J. C., Sutherland, A. G., Lee, C., Wisdom, R., Thomas, S., Roberts, S. M., Evans, C. T. (1990). Chemoenzymatic synthesis of (-)-carbovir utilizing a whole cell catalysed resolution of 2-azabicyclo[2.2.1]hept-5-en-3-one. J. Chem. Soc. Chem. Commun. 1121.
43. Evans, C. T., Roberts, S. M. (1991). Chiral azabicyloheptanone and a process for their preparation. EP0424064/1991.
44. Taylor, S. J. C., Brown, R. C., Keene, P. A., Taylor, I. N. (1999). Novel screening methods-the key to cloning commercially successful biocatalysts. Bioorg. Med. Chem. 7, 2163-2168.
45. Mahmoudian, M., Lowdon, A., Jones, M., Dawson, M., Wallis, C. (1999). A practical enzymatic procedure for the resolution of N-substituted 2-azabicyclo[2.2.1]hept-5-en-3-one. Tetrahedron Asymmetry 10, 1201-1206.
46. Neuberg, C., Hirsch, J. (1921). Ü ber ein kohlenstoffketten knÜ pfendes ferment (carboligase). Biochem. Z. 115, 282-310.
47. Neuberg, C., Ohle, H. (1922). Zur kenntnis der carboligase. Biochem. Z. 127, 327-337.
48. Netrval, J., Vojtisek, V. (1982). Production of phenylacetyl carbinol in various yeast species. Eur. J. Appl. Microbiol. Biotechnol. 16, 35-38.
49. Mandwal, A. K., Tripathi, C. K. M., Trivedi, P. D., Joshi, A. K., Agarwal, S. C., Bihari, V. (2004). Production of l-phenylacetyl carbinol by immobilized cells of Saccharomuces cerevisiae. Biotechnol. Lett. 26, 217-221.
50. Mahmoud, W. M., El-Sayed, A. H. M. M., Coughlin, R. W. (1990). Production of l-phenylacetylcarbinol by immobilized yeast cells, I & II. Biotechnol. Bioeng. 36, 47-54 & 55-63.
51. Rosche, B., Sandford, V., Breuer, M., Hauer, B., Rogers, P. L. (2002). Enhanced production of R-phenylacetylcarbinol (R-PAC) through enzymatic biotransformation. J. Mol. Catal. B Enzym. 19-20, 109-115.
52. Rosche, B., Breuer, M., Hauer, B., Rogers, P. L. (2004). Biphasic aqueous/organic biotransformation of acetaldehyde and benzaldehyde by Zymomonas mobilis pyruvate decarboxylase. Biotechnol. Bioeng. 86, 788-794.
53. Breuer, M., Ditrich, K., Habicher, T., Hauer, B., Keßeler, M., Stürmer, R., Zelinski, T. (2004). IndustrialMethods for the production of optically active intermediates, Angew. Chem. Int. Ed, 43, 788-824.
54. Panke, S., Wubbolts, M. (2005). Advances in biocatalytic synthesis of pharmaceutical intermediates. Curr. Opin. Chem. Biol. 9, 188-194.
55. Yamamoto, A., Yokozeki, K., Kubota, K. (1987). Enzymic manufacture of aromatic amino acids. JP 01010995.
56. De Ninno, M. P. (1991). The synthesis and glycosidation of N-acetyl-dneuraminic acid. Synthesis 8, 583-593.
57. Mahmoudian, M. (2006). A decade of biocatalysis at Glaxo Wellcome. In Biocatalysis in the Pharmaceutical and Biotechnology Industries, Ed R. N. Patel, Wiley, chapter 3.
58. Dawson, M. J., Noble, D., Mahmoudian, M. (1994). Process for the preparation of N-acetyl-d-neuraminic acid. WO1994/029476.
59. Mahmoudian, M., Noble, D., Drake, C. S., Middleton, R. F., Montgomery, D. S., Piercey, J. E., Ramlakhan, D., Todd, M., Dawson, M. J. (1997). An efficient process for production of Nacetylneuraminic acid using N-acetylneuraminic acid aldolase. Enzyme Microbial Technol. 20, 393-400.
60. Roth, B. D. (2002). The discovery and development of atorvastatin, a potent novel hypolipidemic agent. Prog. Medicinal Chem. 40, 1-22.
61. Baumann, K. L., Bulter, D. E., Deering, C. F., Mennen, K. E., Millar, A., Nanninga, T. N., Palmer, C. W., Roth, B. D. (1992). The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase. Tetrahedron Lett. 33, 2283-2284.
62. Müller, M. (2005). Chemoenzymatic synthesis of building blocks for statin side chains. Angem. Chem. Int. Ed. 44, 362-365.
63. Panke, S., Wubbolts, M. (2005). Advances in biocatalytic synthesis of pharmaceutical intermediates. Curr. Opin. Chem. Biol. 9, 188-194.
64. Gijsen, H. J. M., Wong, C. H. (1994). Unprecedented asymmetric aldol reaction with three aldehyde substrate catalyzed by 2-deoxyribose-5-phosphate aldolase. J. Am. Chem. Soc. 116, 8422-8423.
65. Kierkels, J. G. T., Mink, D., Panke, S., Lommen, F. A. M., Heemskerk, D. (2003). Process for the preparation of 2, 4-dideoxyhexoses 2, 4, 6,-trideoxyhexoses. WO 2003/006656.
66. Greenberg, W. A., Varvak, A., Hanson, S. R., Wong, K., Huang, H., Burk, M. J. (2004). Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates. Proc. Natl. Acad. Sci. U. S. A. 101, 5788-5793.
67. Liu, J., Hsu, C. C., Wong, C. H. (2004). Sequential aldol condensation catalyzed by DERA mutant Ser238Asp and a formal total synthesis of atovastatin. Tetrahedron Lett. 45, 2439-2441.
68. Patel, R. N., Banerjee, A., McNamee, C. G., Brzozowski, D., Hanson, R. L., Szarka, L. J. (1993). Enantioselective microbial reduction of 3, 5-dioxo-6-(benzyloxy)hexanoic acid ethyl ester. Enzyme Microb. Technol. 15, 1014-1021.
69. Guo, Z., Chen, Y., Goswami, A., Hanson, R. L., Patel, R. N. (2006). Synthesis of ethyl and t-butyl (3R, 5S)-dihydroxy-6-benzyloxyhexanoates via diastereo-and enantioselective microbial reduction. Tetrahedron Asymmetry 17, 1589-1602.
70. Blacklock, T. J., Sohar, P., Butcher, J. W., Lamamnec, T., Grabowski, E. J. J. (1993). An enantioselective synthesis of the topically-active carbonic anhydrase inhibitor MK-0507: 5, 6-dihydro-(S)-(ethylamino)-(S)-6-methyl-4H-thieno[2, 3-b]thiopyran-2-sulfonamide 7, 7-dioxide hydrochloride. J. Org. Chem. 58, 1672-1679.
71. Holt, R. A., Richard, S. R. (1994). Enzymatic asymmetric reduction process to produce 4H-thieno(2, 3-6)thio pyrane derivatives. WO1994/005802.
72. Gelo-Pujic, M., Marion, C., Mauger, C., Michalon, M., Schlama, T., Turconi, J. (2006). Biohydrolysis of (S)-3-(thiophen-2-ylthio)butanenitrile. Tetrahedron Lett. 47, 8119-8123.
73. Kobayashi, M., Shimizu, S. (2000). Nitrile hydrolases. Curr. Opin. Chem. 4, 95-102.
74. Goodhue, C. T., Schaeffer, J. R. (1971). Preparation of l-(+)-hydroxyisobutyric acid by bacterial oxidation of isobutyric acid. Biotechnol. Bioeng. 13, 203-214.
75. Shimazaki, M., Hasegawa, J., Kan, K., Nomura, K., Nose, Y., Kondo, H., Ohashi, T., Watanabe, K. M. (1982). Synthesis of captopril starting from an optically active beta-hydroxy acid. Chem. Pharm. Bull. 30, 3139-3146.
76. Elferink, V. H. M., Kierkels, J. G. T., Kloosterman, M., Roskam, J. H. (1990). Process for the enantioselective preparation of D-(-)-3-hal-2-methylpropionic acid or derivatives thereof and the preparation of captopril there from. EP0369553/1990.
77. Patel, R. N., Howell, J. M., McNamee, C. G., Fortney, K. F., Szarka, L. J. (1992). Stereoselective enzymatic hydrolysis of a-[(acetylthio)methyl]benzenepropanoic acid and 3-acetylthio-2-methylpropanoic acid. Biotechnol. Appl. Biochem. 16, 34-47.
78. Gu, Q. M., Reddy, D. R., Sih C. J. (1986). Bifunctional chiral synthons via biochemical methods. VIII. Optically-active 3-aroylthio-2-methylpropionic acids. Tetrahedron Lett. 27, 5203-5206.
79. Chen, C. S., Fujimoto, Y., Girdaukas, G., Sih, C. J. (1982). Quantitative analyses of biochemical kinetic resolutions of enantiomers. J. Am. Chem. Soc. 104(25), 7294-7299.
80. Sih, C. J. (1987). Process for preparing optically active 3-acylthio-2-methylpropionic acid derivatives. WO1987/005328.
81. Levadoux, W., Groleau, D., Trani, M., Lortie, R. (1998). Streptomyces microorganism useful for the preparation of (R)-baclofen from the racemic mixture. US1998/5843765.
82. Chênevert, R., Desjardins, M. (1994). Chemoenzymatic enantioselective synthesis of baclofen. Can. J Chem. 72, 2312-2317.
83. Schoenfelder, A., Mann, A., Le Coz, S. (1993). Enantioselective synthesis of (R)-(-)-baclofen. Synlett 7, 63-64.
84. Herdeis, C., Hubmann, H. P. (1992). Synthesis of homochiral Rbaclofen from S-glutamic acid. Tetrahedron Asymm. 3, 1213-1221.
85. Hubmann, H. P., Herdeis, C. (1994). Process for preparing enantiomer-pure (beta)-substituted (gamma)-aminobutyric acid derivatives, new enantiomer-pure intermediate stages of said process and their ues. WO 1994/02443.
86. Vaccher, C., Berthelot, P., Flouquet, N., Debaert, M. (1991). Preparative liquid chromatographic separation of isomers of 4-amino-3-(4-chlorophenyl)butyric acid. J. Chromatogr. A 542, 502-507.
87. Resende, P., Almeida, W. P., Coelho, F. (1999). An efficient synthesis of (R)-(-)-baclofen. Tetrahedron Asymm. 10, 2113-2118.
88. Chenevert, R., Desjardins, M. (1991). Chemoenzymatic synthesis of both enantiomers of baclofen. Tetrahedron Lett. 32, 4249-4250.
89. Maxxini, C., Lebreton, J., Alphand, V. (1997). A chemoenzymatic strategy for the synthesis of enantiopure (R)-(-)-baclofen. Tetrahedron Lett. 38, 1195.
90. Li, J. W. H., Vederas, J. C. (2009). Drug discovery and natural products: end of an era or an endless frontier?. Science 325, 161-165.
91. Butler, M. S. (2008). Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Rep. Art. 25, 475-516.
92. Newman, D. J., Cragg, G. M. (2007). Natural products as sources of new drugs over the last 25 years. J Natural Products 70, 461-477.
93. Stephanopoulos G. (1999). Metabolic fluxes and metabolic engineering. Metabol. Eng. 1, 1-11.
94. Raab, R. M., Tyo, K., Stephanopoulos, G. (2005). Metabolic engineering. Adv. Biochem. Eng. Biotechnol. 100, 1-17.
95. Friehs, K. (2004). Plasmid copy number and plasmid stability. Adv. Biochem. Eng. Biotechnol. 86, 47-82.
96. Antoine, R., Locht, C. (1992). Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from Gram-positive organisms. Mol. Microbiol. 6, 1785-1799.
97. Tao, L., Jackson, R. E., Cheng, Q. (2005). Directed evolution of copy number of a broad host range plasmid for metabolic engineering. Evol. Eng. 7, 10-17.
98. Keasling, J. D. (1999). Gene-expression tools for the metabolic engineering of bacteria. Trends Biotechnol. 17, 452-460.
99. Iwatani, S., Yamada, Y., Usuda, Y. (2008). Metabolic flux analysis in biotechnology processes. Biotechnol. Lett. 30, 791-799.
100. Cane, D. E., Walsh, C. T., Khosla, C. (1998). Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 282, 63-68.
101. Khosla, C., Harbury, P. B. (2001). Modular enzymes. Nature 409, 247-252.
102. Pfeifer, B. A., Admiraal, S. J., Gramajo, H., Cane, D. E., Khosla, C. (2001). Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291, 1790-1792.
103. Walsh, C. T. (2003). Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press.
104. Neu, H. C. (1992). The crisis in antibiotic resistance. Science 257, 1064-1073.
105. Kennedy, J., Turner, G. (1996). d-l-a-aminoadipyl-l-cysteinyl-d-valine synthetase is a rate limiting enzyme for penicillin production in Aspergillus nidulans. Mol. Gen. Genet. 253, 189-197.
106. Kreisberg-Zakarin, R., Borovok, I., Yanko, M., Aharonowitz, Y., Cohen, G. (1999). Recent advances in the structure and function of isopenicillin N synthase. Antonie van Leeuwenhoek 75, 33-39.
107. Martin, J. F. (1998). New aspects of genes and enzymes for ß-lactam antibiotic biosynthesis. Appl. Microbiol. Biotechnol. 50, 1-15.
108. Waites, M. J., Morgan, N. L., Rockey, J. S., Higton, G. (2001). Industrial microbiology: An Introduction. Oxford, UK: Blackwell.
109. Nistelrooij, V., Krijgsman, J., DeVroom, E., Oldenhof, C. (1998). Penicillin update. In: Mateles RI (ed). Penicillin: A Paradigm for Biotechnology. Chicago, IL: Candida, p. 85-91.
110. Elander, R. P. (2003). Industrial production of b-lactam antibiotics. Appl Microbiol Biotechnol. 61, 385-392.
111. Skatrud, P. L., Tietz, A. J., Ingolia, T. D., Cantwell, C. A., Fisher, D. L., Chapman, J. L., Queener, S. W. (1989). Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium. Nat. Biotechnol. 7, 477-485.
112. Clausen, K., Dekkers, R. M. (1996). ß-Lactam antibiotic production by enzymatic acylation. (Bist-brocades B.V.), WO 9602663.
113. Diender, M. B., Straathof, A. J. J., van der Does, T., Zomerdijk, M., Heijnen, J. J. (2000). Course of pH during the formation of amoxicillin by a suspension-to-suspension reaction. Enzyme Microbial Technol. 27, 576-582.
114. van der Drift, J. K., Henniger, P. W., van Veen, G. J. (1978). 6-(d-a-Amino-phydroxyphenylacetamido)-penicillanic acid preparation. US 4128547.
115. Usher, J. J., Romancik, G. (1998). Synthesis of ß-lactam antibacterials using soluble side chain esters and enzymatic acylase. (Bristol-Meyers Squibb Co.), WO 9804732.
116. Lopez-Gallego, F., Batencor, L., Hidalgo, A., Mateo, C., Fernandez-Lafuente, R., Guisan, J. M. (2005). One-pot conversion of cephalosporin C to 7-aminocephalosporanic acid in the absence of hydrogen peroxide. Adv. Synth. Catal. 347, 1804-1810.
117. Tan, H. S., Verweij, J. (1975). One-step, high yield conversion of penicillin sulfoxides to deacetoxycephalosporins. J. Org. Chem. 40, 1346-1347.
118. Verweij, J., Tan, H. S., Kooreman, H. J. (1977). Preparation of 7-substituted amino-desacetoxycephalosporanic acid compounds. (Gist-brocades N.V.), US Patent 4003894.
119. Faarup, P. (1977). Method of preparing a sparingly soluble complex of cephalexin (Novo Industri A/S). US Patent 4003896,.
120. Kemperman, G. J., de Gelder, R., Dommerholt, F. J., Raemakers-Franken, P. C., Klunder, A. J. H., Zwanenburg, B. (1999). Clathrate-type complexation of cephalosporins with ß-naphthol. Chem. Eur. J. 5, 2163-2168.
121. Wegman, M. A., van Langen, L. M., van Rantwijk, F., Sheldon, R. A. (2002). A two-step, one-pot enzymatic synthesis of cephalexin from d-phenylglycine nitrile. Biotechnol. Bioeng. 79, 356-361.
122. Singh, J., Denzel, T. W., Fox, R., Kissick, T. P., Herter, R., Wurdinger, J., Schierling, P., Papaioannou, C. G., Moniot, J. L., Mueller, R. H., Cimarusti, C. M. (2002). Regioselective activation of aminothiazole (iminoxyacetic acid) acetic acid: an efficient synthesis of the monobactam aztreonam. Org. Process Res. Dev. 6, 863-868.
123. Pendland, S. L., Messick, C. R., Jung, R. (2002). In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa. Diagnostic Microbiol. Infect. Dis. 42, 75-78.
124. Kahan, J. S., Kahan, F. M., Goegelman, R., Currie, S. A., Jackson, M., Stapley, E. O., Miller, T. W., Hendlin, D., Mochales, S., Hernandez, S., Woodrull, H. B., Birnbaum, J. (1979). Thienamycin, a new betalactam antibiotic. 1. Discovery, taxonomy, isolation and physical properties. J Antibiot. 32, 1-12.
125. Stapon, A., Li, R., Townsend, C. A. (2003). Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from l-proline. J Am Chem Soc. 125, 8486-8493.
126. Bodner, M. J., Phelan, R. M., Townsend, C. A. (2009). A catalytic asymmetric route to carbapenems. Org. Lett. 11, 3606-3609.
127. Demain, A. L., Vaishnav, P. (2006). Involvement of nitrogen-containing compounds in ß-lactam biosynthesis and its control. Crit. Rev. Biotechnol. 26, 67-82.
128. Lawrence, G. C., Lilly, G. (1980). Clavulanic acid production. UK Patent GB1571888.
129. Xiang, S. H., Li, J., Yin, H., Zheng, J. T., Yang, X., Wang, H. B., Luo, J. L., Bai, H., Yang, K. Q. (2009). Application of a double-reporter-guided mutant selection method to improve clavulanic acid production in Streptomyces clavuligerus. Metab. Eng. 11, 310-318.
130. Silva, C. S., Bovarotti, E., Rodrigues, M. I., Hokka, C. O., Barboza, M. (2009). Evaluation of the effects of the parameters involved in the purification of clavulanic acid from fermentation broth by aqueous two-phase systems. Bioprocess Biosyst. Eng. 32, 625-632.
131. Taniguchi, M., Sasaoka, M., Matsumara, K., Kanahara, I., Kaze, K., Suzuki, D., Shimabayashi, A. A. (1989). Preparation of ß-lactamase inhibiting triazolecontaining ß-lactam. EP 0331146.
132. Xu, W. L., Li, Y. Z., Zhang, Q. S., Zhu, H. S. (2005). A new approach to the synthesis of tazobactam using an organosilver compound synthesis of tazobactam. Synthesis 3, 442-446.
133. McDaniel, R., Licari, P., Khosla, C. (2001). Process development and metabolic engineering for the overproduction of natural and unnatural polyketides. Metab. Eng. 73, 31-52.
134. Shen, B. (2003). Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms. Curr. Opin. Chem. Biol. 7, 285-295.
135. Staunton, J., Weissman, K. J. (2001). Polyketide biosynthesis: a millennium review. Natural Product Rep. 18, 380-416.
136. Smith, R. L., Bungay, H. R., Pittenger, R. C. (1962). Growth-biosynthesis relationships in erythromycin fermentation. Appl. Microbiol. 10, 293-296.
137. El-Enshasy, H. A., Mohamed, N. A., Farid, M. A., El-Diwany, A. I. (2008). Improvement of erythromycin production by Saccharopolyspora erythraea in molasses based medium through cultivation medium optimization. Bioresource Technol. 99, 4263-4268.
138. Zou, X., Hang, H. F., Chu, J., Zhuang, Y. P., Zhang, S. L. (2009). Enhancement of erythromycin a production with feeding available nitrogen sources in erythromycin biosynthesis phase. Bioresource Technol. 100, 3358-3365.
139. Cortes, J., Haydock, S. F., Roberts, G. A., Bevitt, D. J., Leadlay, P. F. (1990). An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea. Nature 348, 176-178.
140. Peiru, S., Menzella, H. G., Rodriguez, E., Carney, J., Gramajo, H. (2005). Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl. Environ. Microbiol. 71, 2539-2547.
141. Lee, H. Y., Khosla, C. (2007). Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biol. 5, e45.
142. Lomovskaya, N., Otten, S. L., Doi-Katayama, Y., Fonstein, L., Liu, X. C., Takatsu, T., Inventi-Solari, A., Filippini, S., Torti, F., Colombo, A. L., Hutchinson, C. R. (1999). Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. J. Bacteriol. 181, 305-318.
143. Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., Spalla, C. (2000). Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Biotechnol. Bioeng. 67, 704-713.
144. Dickens, M. L., Strohl, W. R. (1996). Isolation and characterization of a gene from Streptomyces sp. strain C5 that confers the ability to convert daunomycin to doxorubicin on Streptomyces lividans TK24. J. Bacteriol. 178, 3389-3395.
145. Walczak, R. J., Dickens, M. L., Priestley, N. D., Strohl, W. R. (1999). Purification, properties, and characterization of recombinant Streptomyces sp. strain C5 DoxA, a cytochrome P-450 catalyzing multiple steps in doxorubicin biosynthesis. J. Bacteriol. 181, 298-304.
146. Grimm, A., Madduri, K., Ali, A., Hutchinson, C. R. (1994). Characterization of the Streptomyces peucetius ATCC 29050 genes encoding doxorubicin polyketide synthase. Gene 151, 1-10.
147. Lomovskaya, N., Otten, S. L., Doi-Katayama, Y., Fonstein, L., Liu, X. C., Takatsu, T., Inventi-Solari, A., Filippini, S., Torti, F., Colombo, A. L., Hutchinson, C. R. (1999). Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. J. Bacteriol. 181, 305-318.
148. http://www.solvias.com.
149. Hutchinson, C. R. (1997). Biosynthetic studies of daunorubicin and tetracenomycin C. Chem. Rev. 97, 2525-2535.
150. Weber, W., Z̈ahner, H., Siebers, J., Schr̈oder, K., Zeeck, A. (1979). Metabolic products of microorganisms. 175. Tetracenomycin-C. Arch. Microbiol. 121, 111-116.
151. Shen, B. (2000). Biosynthesis of aromatic polyketides. Top. Curr. Chem. 209, 1-51.
152. Suffness, M., Wall, M. E. (1995). Discovery and development of taxol. In: Suffness M (ed) Taxol-Science and Applications. Boca Raton, FL: CRC Press, p. 3-25.
153. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., McPhail, A. T. (1971). Plant antitumor agents VI: The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325-2327.
154. Wuts, P. G. M. (1998). Semisynthesis of taxol. Curr. Opin. Drug Discov. Dev. 1, 329-337.
155. Holton, R. A. (1990). Method for preparation of taxol. EP 0400971 A2.
156. Tabata, H. (2004). Paclitaxel production by plant-cell-culture technology. Adv. Biochem. Eng. Biotechnol. 7, 1-23.
157. http://www.phytonbioth.com.
158. Itokawa, H. (2003). Taxoids occurring in the genus taxus. In: Itokawa H & Lee K-H (eds). Taxus-The Genus Taxus. London, UK: Taylor & Francis, p. 35-78.
159. Son, S. H., Choi, S. M., Lee, Y. H., Choi, K. B., Yun, S. R., Kim, J. K., Park, H. J., Kwon, O. W., Noh, E. W., Seon, J. H., Park, Y. G. (2001). Large-scale growth and taxane production in cell cultures of Taxus cuspidate (Japanese yew) using a novel bioreactor. Plant Cell Rep. 19, 628-633.
160. Seki, M., Ohzora, C., Takeda, M., Furusaki, S. (1997). Taxol (paclitaxel) production using free and immobilized cells of Taxus cuspidata. Biotechnol. Bioeng. 53, 214-219.
161. Zhao, J., Davis, L. C., Verpoorte, C. (2005). Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnol. Adv. 23, 283-333.
162. Yukimune, Y., Tabata, H., Higashi, Y., Hara, Y. (1996). Methyl jasmonate induced over-production of paclitaxel and baccatin III in Taxus cell suspension cultures. Nat. Biotechnol. 14, 1129-1132.
163. Zhang, C. H., Wu, J. Y. (2003). Ethylene inhibitors enhance elicitor-induced paclitaxel production in suspension cultures of Taxus spp. cells. Enzyme Microbial Technol. 32, 71-77.
164. Reymond, P., Bodenhausen, N., van Poecke, R. M. P., Krishnamurthy, V., Dicke, M., Farmer, E. (2004). A conserved transcript pattern in response to a specialist and a generalist herbivore. Plant Cell 16, 3132-3147.
165. Bentebibel, S., Moyano, T., Palazon, J., Cusidó, R. M., Bonfill, M., Eibl, R., Piñol, T. (2005). Effects of immobilization by entrapment in alginate and scale-up on paclitaxel and baccatin III production in cell suspension cultures of Taxus baccata. Biotechnol. Bioeng. 89, 647-655.
166. Stierle, A., Strobel, G. (1993). Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific yew. Science 260, 214-216.
167. Roberts, S. C. (2007). Production and engineering of terpenoids in plant cell culture. Nat. Chem. Biol. 3, 387-395.
168. Zhao, K., Ping, W., Li, Q., Hao, S., Zhao, L., Gao, T., Zhou, D. (2009). Aspergillus niger var. taxi, a new species variant of taxol-producing fungus isolated from Taxus cuspidata in China. J. Appl. Microbiol. 107, 1202-1207.
169. Xu, F., Tao, W. Y., Cheng, L., Guo, L. J. (2006). Strain improvement and optimization of the media of taxol-producing fungus, Fusarium mairei. Biochem. Eng. J. 31, 67-73.
170. Li, Y. C., Tao, W. Y., Cheng, L. (2009). Paclitaxel production using co-culture of Taxus suspension cells and paclitaxel-producing endophytic fungi in a co-bioreactor. Appl. Microbiol. Biotechnol. 83, 233-239.
171. Lyseng-Williamson, K. A., Fenton, C. (2005). Docetaxel: a review of its use in metastatic breast cancer. Drugs 65, 2513-2531.
172. Commerçon, A., Bernard, F., Bézard, D., Bourzat, J. D. (1992). Improved protection and esterification of a precursor of the Taxotere® and taxol side chains. Tetrahedron Lett. 33, 5185-5188.
173. Gaetan, C., Mettilda, L. (2009). Preparation of taxanes from 9-dihydro-13-acetylbaccatin III. US 0062376 A1.
174. Walsh, C. T. (2002). Combinatorial biosynthesis of antibiotics: challenges and opportunities. Chembiochem 3, 125-134.
175. Liu, W., Yu, Y. (2008). Combinatorial biosynthesis of pharmaceutical natural product. In Biocatalysis for the Pharmaceutical Industry-Discovery, Development, and Manufacturing. Ed. by Tao, J. H., Lin, G. Q., Liese, A. John Wiley & Sons, chapter 11, p. 229-246.